Related references
Note: Only part of the references are listed.Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Altered pharmacokineties of voriconazole in a patient with liver cirrhosis
Stefan Weiler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacology of systemic antifungal agents
Elizabeth S. Dodds Ashley et al.
CLINICAL INFECTIOUS DISEASES (2006)
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections
Jan G. den Hollander et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Correlation of MIC with outcome for Candida species tested against voriconazole:: Analysis and proposal for interpretive breakpoints
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities
K Tan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
S Schwartz et al.
BLOOD (2005)
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients
I Mohammedi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest®:: results of a French multicentre study
M Mallié et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Interaction between voriconazole and tacrolimus in a kidney-transplanted patient
M Tintillier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
S Trifilio et al.
BONE MARROW TRANSPLANTATION (2005)
Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods
MJ Linares et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Guidelines for treatment of candidiasis
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Safety of voriconazole and dose individualization
I Lutsar et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole: A new triazole antifungal agent
LB Johnson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients
AJ Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis
AM Sugar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
